Longevity-focused health management platform Function Health has partnered with GRAIL, Inc., a healthcare company focusing on early cancer detection and treatment, to expand access to revolutionary cancer screening. As reported earlier by HIT, the partnership allows over 400,000 Function Health customers access to GRAIL’s first-of-its-kind test called the Galleri test. The multi-cancer early detection (MCED) test is designed to screen for many types of cancers from just a single blood draw, adding to the company’s list of over 100 lab tests.